LESLIE MORTON: Open Payments
NPI 1528790425 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$844 in 45 payments from 14 companies in 2025. Trend: 2023 $899 · 2024 $1,175 · 2025 $844
Food & beverage: $844
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $194 |
| Kestra Medical Technology Services, Inc. | 16 | $166 |
| Novo Nordisk Inc | 5 | $100 |
| AstraZeneca Pharmaceuticals LP | 4 | $92 |
| CVRx, Inc. | 3 | $72 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $41 |
| Amgen Inc. | 1 | $28 |
| ABIOMED | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
Products named: LEQVIO, Assure WCD, Wegovy, Barostim Neo System, WAINUA, LifeVest, REPATHA, JARDIANCE.
Industry payments across NC — which companies pay providers there.
